Risk factors for cardiovascular events in patients with heterozygous familial hypercholesterolaemia: protocol for a systematic review

Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia

(2021) Martine Paquette et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Dyslipidemia and aortic valve disease

(2021) Pedro Mata et al.   CURRENT OPINION IN LIPIDOLOGY

Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

(2020) Gerald F. Watts et al.   Nature Reviews Cardiology

Prevalence of Familial Hypercholesterolemia Among the General Population and Patients With Atherosclerotic Cardiovascular Disease

(2020) Pengwei Hu et al.   CIRCULATION

Lipoprotein(a), LDL-cholesterol, and hypertension: predictors of the need for aortic valve replacement in familial hypercholesterolaemia

(2020) Leopoldo Pérez de Isla et al.   EUROPEAN HEART JOURNAL

Integrated Guidance for Enhancing the Care of Familial Hypercholesterolaemia in Australia

(2020) Gerald F. Watts et al.   Heart Lung and Circulation

Risk of Premature Atherosclerotic Disease in Patients With Monogenic Versus Polygenic Familial Hypercholesterolemia

(2019) Mark Trinder et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association of Low-Density Lipoprotein Cholesterol With Risk of Aortic Valve Stenosis in Familial Hypercholesterolemia

(2019) Liv J. Mundal et al.   JAMA Cardiology

Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies

(2019) David S. Wald et al.   ATHEROSCLEROSIS

HEART UK consensus statement on Lipoprotein(a): A call to action

(2019) Jaimini Cegla et al.   ATHEROSCLEROSIS

Familial hypercholesterolemia and elevated lipoprotein(a): double heritable risk and new therapeutic opportunities

(2019) A. Vuorio et al.   JOURNAL OF INTERNAL MEDICINE

The characteristics of patients with possible familial hypercholesterolemia—screening a large payer/provider healthcare delivery system

(2019) A Elis et al.   QJM-AN INTERNATIONAL JOURNAL OF MEDICINE

A Comparative Analysis of Phenotypic Predictors of Mutations in Familial Hypercholesterolemia

(2018) Dick C Chan et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

ABO blood group is a cardiovascular risk factor in patients with familial hypercholesterolemia

(2018) Martine Paquette et al.   Journal of Clinical Lipidology

The complex molecular genetics of familial hypercholesterolaemia

(2018) Amanda J. Berberich et al.   Nature Reviews Cardiology

Familial hypercholesterolemia and risk of peripheral arterial disease and chronic kidney disease

(2018) Frida Emanuelsson et al.   JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM

Clinical Genetic Testing for Familial Hypercholesterolemia

(2018) Amy C. Sturm et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018

(2018) Liam R. Brunham et al.   CANADIAN JOURNAL OF CARDIOLOGY

Risk factors for cardiovascular disease in heterozygous familial hypercholesterolemia: A systematic review and meta-analysis

(2018) Leo E. Akioyamen et al.   Journal of Clinical Lipidology

Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia

(2017) Hayato Tada et al.   EUROPEAN HEART JOURNAL

Familial hypercholesterolemia in a European Mediterranean population—Prevalence and clinical data from 2.5 million primary care patients

(2017) Alberto Zamora et al.   Journal of Clinical Lipidology

Cost-effectiveness of a cascade screening program for the early detection of familial hypercholesterolemia

(2017) Pablo Lázaro et al.   Journal of Clinical Lipidology

Coronary Heart Disease, Peripheral Arterial Disease, and Stroke in Familial HypercholesterolaemiaHighlights

(2016) Leopoldo Pérez de Isla et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Epicardial fat is associated with severity of subclinical coronary atherosclerosis in familial hypercholesterolemia

(2016) Leonardo C. Mangili et al.   ATHEROSCLEROSIS

Cardiovascular Disease Risk Associated With Familial Hypercholesterolemia: A Systematic Review of the Literature

(2016) Bruce Wong et al.   CLINICAL THERAPEUTICS

Proprotein convertase subtilisin/kexin 9 V4I variant with LDLR mutations modifies the phenotype of familial hypercholesterolemia

(2016) Naotaka Ohta et al.   Journal of Clinical Lipidology

Diagnostic Yield and Clinical Utility of Sequencing Familial Hypercholesterolemia Genes in Patients With Severe Hypercholesterolemia

(2016) Amit V. Khera et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Genetic identification of familial hypercholesterolemia within a single U.S. health care system

(2016) Noura S. Abul-Husn et al.   SCIENCE

Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel

(2016) Raul D Santos et al.   Lancet Diabetes & Endocrinology

The Agenda for Familial Hypercholesterolemia

(2015) Samuel S. Gidding et al.   CIRCULATION

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation

(2015) L. Shamseer et al.   BMJ-British Medical Journal

Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia

(2014) Jacques Genest et al.   CANADIAN JOURNAL OF CARDIOLOGY

Integrated guidance on the care of familial hypercholesterolaemia from the International FH Foundation

(2013) Gerald F. Watts et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

GRADE guidelines: 3. Rating the quality of evidence

(2011) Howard Balshem et al.   JOURNAL OF CLINICAL EPIDEMIOLOGY